{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T22:47:22Z","timestamp":1783205242370,"version":"3.54.6"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00392-025-02624-5","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T09:42:18Z","timestamp":1740735738000},"page":"899-915","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Percutaneous left atrial appendage closure for stroke prevention: current challenges and future perspectives"],"prefix":"10.1007","volume":"115","author":[{"given":"Carla","family":"Rochira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mazzapicchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore Davide","family":"Tomasello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore Adriano","family":"Azzarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Di Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Scardaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Argentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"issue":"7","key":"2624_CR1","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/str.0000000000000375","volume":"52","author":"DO Kleindorfer","year":"2021","unstructured":"Kleindorfer DO et al (2021) 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association (in eng). Stroke 52(7):e364\u2013e467. https:\/\/doi.org\/10.1161\/str.0000000000000375","journal-title":"Stroke"},{"issue":"2","key":"2624_CR2","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1161\/01.str.32.2.392","volume":"32","author":"M Lamassa","year":"2001","unstructured":"Lamassa M et al (2001) Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project) (in eng). Stroke 32(2):392\u2013398. https:\/\/doi.org\/10.1161\/01.str.32.2.392","journal-title":"Stroke"},{"issue":"9921","key":"2624_CR3","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/s0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT et al (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials (in eng). Lancet 383(9921):955\u2013962. https:\/\/doi.org\/10.1016\/s0140-6736(13)62343-0","journal-title":"Lancet"},{"issue":"15","key":"2624_CR4","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1136\/heartjnl-2012-301799","volume":"98","author":"R Mahajan","year":"2012","unstructured":"Mahajan R et al (2012) Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure (in eng). Heart 98(15):1120\u20131126. https:\/\/doi.org\/10.1136\/heartjnl-2012-301799","journal-title":"Heart"},{"issue":"9658","key":"2624_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/s0140-6736(09)60040-4","volume":"373","author":"T Watson","year":"2009","unstructured":"Watson T, Shantsila E, Lip GY (2009) Mechanisms of thrombogenesis in atrial fibrillation: Virchow\u2019s triad revisited (in eng). Lancet 373(9658):155\u2013166. https:\/\/doi.org\/10.1016\/s0140-6736(09)60040-4","journal-title":"Lancet"},{"issue":"3","key":"2624_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/circoutcomes.119.005969","volume":"13","author":"AF Ozaki","year":"2020","unstructured":"Ozaki AF et al (2020) Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis (in eng). Circ Cardiovasc Qual Outcomes 13(3):e005969. https:\/\/doi.org\/10.1161\/circoutcomes.119.005969","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"12","key":"2624_CR7","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1161\/strokeaha.114.006929","volume":"45","author":"ER McGrath","year":"2014","unstructured":"McGrath ER et al (2014) Antithrombotic therapy after acute ischemic stroke in patients with atrial fibrillation (in eng). Stroke 45(12):3637\u20133642. https:\/\/doi.org\/10.1161\/strokeaha.114.006929","journal-title":"Stroke"},{"issue":"13","key":"2624_CR8","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.4244\/eijy19m08_01","volume":"15","author":"M Glikson","year":"2020","unstructured":"Glikson M et al (2020) EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion\u2014an update (in eng). EuroIntervention 15(13):1133\u20131180. https:\/\/doi.org\/10.4244\/eijy19m08_01","journal-title":"EuroIntervention"},{"issue":"19","key":"2624_CR9","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1001\/jama.2014.15192","volume":"312","author":"VY Reddy","year":"2014","unstructured":"Reddy VY et al (2014) Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial (in eng). JAMA 312(19):1988\u20131998. https:\/\/doi.org\/10.1001\/jama.2014.15192","journal-title":"JAMA"},{"issue":"1","key":"2624_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","volume":"64","author":"DR Holmes Jr","year":"2014","unstructured":"Holmes DR Jr et al (2014) Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial (in eng). J Am Coll Cardiol 64(1):1\u201312. https:\/\/doi.org\/10.1016\/j.jacc.2014.04.029","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"2624_CR11","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","volume":"70","author":"VY Reddy","year":"2017","unstructured":"Reddy VY et al (2017) 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials (in eng). J Am Coll Cardiol 70(24):2964\u20132975. https:\/\/doi.org\/10.1016\/j.jacc.2017.10.021","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2624_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/europace\/euw141","volume":"19","author":"A Tzikas","year":"2017","unstructured":"Tzikas A et al (2017) Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies (in eng). Europace 19(1):4\u201315. https:\/\/doi.org\/10.1093\/europace\/euw141","journal-title":"Europace"},{"issue":"23","key":"2624_CR13","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1016\/j.jacc.2019.09.064","volume":"74","author":"DR Holmes Jr","year":"2019","unstructured":"Holmes DR Jr et al (2019) Long-term safety and efficacy in continued access left atrial appendage closure registries (in eng). J Am Coll Cardiol 74(23):2878\u20132889. https:\/\/doi.org\/10.1016\/j.jacc.2019.09.064","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2624_CR14","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.hrthm.2017.05.038","volume":"14","author":"LV Boersma","year":"2017","unstructured":"Boersma LV et al (2017) Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial (in eng). Heart Rhythm 14(9):1302\u20131308. https:\/\/doi.org\/10.1016\/j.hrthm.2017.05.038","journal-title":"Heart Rhythm"},{"issue":"4","key":"2624_CR15","doi-asserted-by":"publisher","DOI":"10.1161\/circep.118.006841","volume":"12","author":"LV Boersma","year":"2019","unstructured":"Boersma LV et al (2019) Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the watchman left atrial appendage closure technology: final 2-Year outcome data of the EWOLUTION trial focusing on history of stroke and hemorrhage (in eng). Circ Arrhythm Electrophysiol 12(4):e006841. https:\/\/doi.org\/10.1161\/circep.118.006841","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"13","key":"2624_CR16","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.jacc.2019.12.040","volume":"75","author":"JV Freeman","year":"2020","unstructured":"Freeman JV et al (2020) The NCDR left atrial appendage occlusion registry (in eng). J Am Coll Cardiol 75(13):1503\u20131518. https:\/\/doi.org\/10.1016\/j.jacc.2019.12.040","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"2624_CR17","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1161\/circulationaha.120.050117","volume":"143","author":"S Kar","year":"2021","unstructured":"Kar S et al (2021) Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial (in eng). Circulation 143(18):1754\u20131762. https:\/\/doi.org\/10.1161\/circulationaha.120.050117","journal-title":"Circulation"},{"issue":"4","key":"2624_CR18","doi-asserted-by":"publisher","first-page":"e026295","DOI":"10.1161\/jaha.122.026295","volume":"12","author":"SK Doshi","year":"2023","unstructured":"Doshi SK et al (2023) 2-year outcomes with a next-generation left atrial appendage device: final results of the PINNACLE FLX Trial (in eng). J Am Heart Assoc 12(4):e026295. https:\/\/doi.org\/10.1161\/jaha.122.026295","journal-title":"J Am Heart Assoc"},{"key":"2624_CR19","unstructured":"Kapadia S, Yeh R, Price M (2022) Real-world outcomes with Watchman FLX: early results from SURPASS. In: Late Breaking Trials Presented at Cardiovascular Research Technologies Meeting in Washington, DC"},{"issue":"30","key":"2624_CR20","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1093\/eurheartj\/ehaa169","volume":"41","author":"D Hildick-Smith","year":"2020","unstructured":"Hildick-Smith D et al (2020) Left atrial appendage occlusion with the Amplatzer\u2122 Amulet\u2122 device: full results of the prospective global observational study (in eng). Eur Heart J 41(30):2894\u20132901. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa169","journal-title":"Eur Heart J"},{"issue":"25","key":"2624_CR21","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","volume":"75","author":"P Osmancik","year":"2020","unstructured":"Osmancik P et al (2020) Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation (in eng). J Am Coll Cardiol 75(25):3122\u20133135. https:\/\/doi.org\/10.1016\/j.jacc.2020.04.067","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2624_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","volume":"79","author":"P Osmancik","year":"2022","unstructured":"Osmancik P et al (2022) 4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation (in eng). J Am Coll Cardiol 79(1):1\u201314. https:\/\/doi.org\/10.1016\/j.jacc.2021.10.023","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"2624_CR23","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1161\/circulationaha.121.057063","volume":"144","author":"D Lakkireddy","year":"2021","unstructured":"Lakkireddy D et al (2021) Amplatzer amulet left atrial appendage occluder versus watchman device for stroke prophylaxis (Amulet IDE): a randomized, controlled trial (in eng). Circulation 144(19):1543\u20131552. https:\/\/doi.org\/10.1161\/circulationaha.121.057063","journal-title":"Circulation"},{"issue":"10","key":"2624_CR24","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/circulationaha.121.057859","volume":"145","author":"R Galea","year":"2022","unstructured":"Galea R et al (2022) Amulet or Watchman device for percutaneous left atrial appendage closure: primary results of the SWISS-APERO randomized clinical trial (in eng). Circulation 145(10):724\u2013738. https:\/\/doi.org\/10.1161\/circulationaha.121.057859","journal-title":"Circulation"},{"issue":"23","key":"2624_CR25","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1016\/j.jacc.2020.08.089","volume":"76","author":"MK Turagam","year":"2020","unstructured":"Turagam MK, Osmancik P, Neuzil P, Dukkipati SR, Reddy VY (2020) Left atrial appendage closure versus oral anticoagulants in atrial fibrillation: a meta-analysis of randomized trials (in eng). J Am Coll Cardiol 76(23):2795\u20132797. https:\/\/doi.org\/10.1016\/j.jacc.2020.08.089","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2624_CR26","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/eurjpc\/zwab018","volume":"29","author":"TJ Siddiqi","year":"2022","unstructured":"Siddiqi TJ et al (2022) Utility of the CHA2DS2-VASc score for predicting ischaemic stroke in patients with or without atrial fibrillation: a systematic review and meta-analysis (in eng). Eur J Prev Cardiol 29(4):625\u2013631. https:\/\/doi.org\/10.1093\/eurjpc\/zwab018","journal-title":"Eur J Prev Cardiol"},{"issue":"10","key":"2624_CR27","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1093\/europace\/eux254","volume":"19","author":"RR Tilz","year":"2017","unstructured":"Tilz RR et al (2017) Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey (in eng). Europace 19(10):1737\u20131742. https:\/\/doi.org\/10.1093\/europace\/eux254","journal-title":"Europace"},{"issue":"8","key":"2624_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/circoutcomes.121.008418","volume":"15","author":"UA Daimee","year":"2022","unstructured":"Daimee UA et al (2022) Indications for left atrial appendage occlusion in the United States and associated in-hospital outcomes: results from the NCDR LAAO registry (in eng). Circ Cardiovasc Qual Outcomes 15(8):e008418. https:\/\/doi.org\/10.1161\/circoutcomes.121.008418","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2624_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euad067","author":"AJ Camm","year":"2023","unstructured":"Camm AJ (2023) Leap or lag: left atrial appendage closure and guidelines. EP Europace. https:\/\/doi.org\/10.1093\/europace\/euad067","journal-title":"EP Europace"},{"issue":"11","key":"2624_CR30","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.jcin.2023.01.011","volume":"16","author":"J Saw","year":"2023","unstructured":"Saw J et al (2023) SCAI\/HRS expert consensus statement on transcatheter left atrial appendage closure (in eng). JACC Cardiovasc Interv 16(11):1384\u20131400. https:\/\/doi.org\/10.1016\/j.jcin.2023.01.011","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"2624_CR31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G et al (2021) 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC (in eng). Eur Heart J 42(5):373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"issue":"1","key":"2624_CR32","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/cir.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar JA et al (2024) 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines (in eng). Circulation 149(1):e1\u2013e156. https:\/\/doi.org\/10.1161\/cir.0000000000001193","journal-title":"Circulation"},{"issue":"5","key":"2624_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrneph.2018.19","volume":"14","author":"TS Potpara","year":"2018","unstructured":"Potpara TS, Ferro CJ, Lip GYH (2018) Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction (in eng). Nat Rev Nephrol 14(5):337\u2013351. https:\/\/doi.org\/10.1038\/nrneph.2018.19","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"2624_CR34","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1161\/strokeaha.120.029267","volume":"51","author":"E Ong","year":"2020","unstructured":"Ong E et al (2020) Prevalence and outcome of potential candidates for left atrial appendage closure after stroke with atrial fibrillation: WATCH-AF registry (in eng). Stroke 51(8):2355\u20132363. https:\/\/doi.org\/10.1161\/strokeaha.120.029267","journal-title":"Stroke"},{"issue":"8","key":"2624_CR35","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jcin.2010.04.017","volume":"3","author":"RS Schwartz","year":"2010","unstructured":"Schwartz RS et al (2010) Left atrial appendage obliteration: mechanisms of healing and intracardiac integration (in eng). JACC Cardiovasc Interv 3(8):870\u2013877. https:\/\/doi.org\/10.1016\/j.jcin.2010.04.017","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"2624_CR36","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jcin.2014.03.003","volume":"7","author":"S Kar","year":"2014","unstructured":"Kar S et al (2014) Impact of Watchman and Amplatzer devices on left atrial appendage adjacent structures and healing response in a canine model (in eng). JACC Cardiovasc Interv 7(7):801\u2013809. https:\/\/doi.org\/10.1016\/j.jcin.2014.03.003","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"2624_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.amjcard.2017.03.253","volume":"120","author":"J Rod\u00e9s-Cabau","year":"2017","unstructured":"Rod\u00e9s-Cabau J et al (2017) Changes in coagulation and platelet activation markers following transcatheter left atrial appendage closure (in eng). Am J Cardiol 120(1):87\u201391. https:\/\/doi.org\/10.1016\/j.amjcard.2017.03.253","journal-title":"Am J Cardiol"},{"issue":"14","key":"2624_CR38","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","volume":"71","author":"L Fauchier","year":"2018","unstructured":"Fauchier L et al (2018) Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation (in eng). J Am Coll Cardiol 71(14):1528\u20131536. https:\/\/doi.org\/10.1016\/j.jacc.2018.01.076","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2624_CR39","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/circulationaha.118.035090","volume":"138","author":"SR Dukkipati","year":"2018","unstructured":"Dukkipati SR et al (2018) Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes (in eng). Circulation 138(9):874\u2013885. https:\/\/doi.org\/10.1161\/circulationaha.118.035090","journal-title":"Circulation"},{"issue":"15","key":"2624_CR40","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.jcin.2015.08.035","volume":"8","author":"MJ Price","year":"2015","unstructured":"Price MJ et al (2015) Bleeding outcomes after left atrial appendage closure compared with long-term warfarin: a pooled, patient-level analysis of the watchman randomized trial experience (in eng). JACC Cardiovasc Interv 8(15):1925\u20131932. https:\/\/doi.org\/10.1016\/j.jcin.2015.08.035","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"2624_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.hrthm.2016.10.020","volume":"14","author":"Y Enomoto","year":"2017","unstructured":"Enomoto Y et al (2017) Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the Watchman device (in eng). Heart Rhythm 14(1):19\u201324. https:\/\/doi.org\/10.1016\/j.hrthm.2016.10.020","journal-title":"Heart Rhythm"},{"issue":"12","key":"2624_CR42","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.jacep.2017.02.013","volume":"3","author":"AF Barakat","year":"2017","unstructured":"Barakat AF et al (2017) Initial experience with non-vitamin K antagonist oral anticoagulants for short-term anticoagulation after left atrial appendage closure device (in eng). JACC Clin Electrophysiol 3(12):1472\u20131473. https:\/\/doi.org\/10.1016\/j.jacep.2017.02.013","journal-title":"JACC Clin Electrophysiol"},{"issue":"12","key":"2624_CR43","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/clc.22478","volume":"38","author":"LI B\u00f6sche","year":"2015","unstructured":"B\u00f6sche LI, Afshari F, Sch\u00f6ne D, Ewers A, M\u00fcgge A, Gotzmann M (2015) Initial experience with novel oral anticoagulants during the first 45 days after left atrial appendage closure with the watchman device (in eng). Clin Cardiol 38(12):720\u2013724. https:\/\/doi.org\/10.1002\/clc.22478","journal-title":"Clin Cardiol"},{"issue":"18","key":"2624_CR44","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.jacc.2022.02.047","volume":"79","author":"JV Freeman","year":"2022","unstructured":"Freeman JV et al (2022) Antithrombotic therapy after left atrial appendage occlusion in patients with atrial fibrillation (in eng). J Am Coll Cardiol 79(18):1785\u20131798. https:\/\/doi.org\/10.1016\/j.jacc.2022.02.047","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2624_CR45","doi-asserted-by":"publisher","DOI":"10.1161\/circinterventions.119.008481","volume":"13","author":"G Duthoit","year":"2020","unstructured":"Duthoit G et al (2020) Reduced rivaroxaban dose versus dual antiplatelet therapy after left atrial appendage closure: ADRIFT a randomized pilot study (in eng). Circ Cardiovasc Interv 13(7):e008481. https:\/\/doi.org\/10.1161\/circinterventions.119.008481","journal-title":"Circ Cardiovasc Interv"},{"key":"2624_CR46","unstructured":"Xavier Freixa M (2023) PhD Low-dose direct oral anticoagulation vs. DAPT after LAAO, ed. In: Presented at: EuroPCR 2023, Paris"},{"key":"2624_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd8110142","author":"PL Cepas-Guillen","year":"2021","unstructured":"Cepas-Guillen PL et al (2021) Low dose of direct oral anticoagulants after left atrial appendage occlusion (in eng). J Cardiovasc Dev Dis. https:\/\/doi.org\/10.3390\/jcdd8110142","journal-title":"J Cardiovasc Dev Dis"},{"issue":"21","key":"2624_CR48","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1016\/j.jcin.2021.07.031","volume":"14","author":"DG Della Rocca","year":"2021","unstructured":"Della Rocca DG et al (2021) Half-dose direct oral anticoagulation versus standard antithrombotic therapy after left atrial appendage occlusion (in eng). JACC Cardiovasc Interv 14(21):2353\u20132364. https:\/\/doi.org\/10.1016\/j.jcin.2021.07.031","journal-title":"JACC Cardiovasc Interv"},{"issue":"22","key":"2624_CR49","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1016\/j.jcin.2023.08.013","volume":"16","author":"M Coylewright","year":"2023","unstructured":"Coylewright M et al (2023) DAPT is comparable to OAC following LAAC with watchman flx: a national registry analysis (in eng). JACC Cardiovasc Interv 16(22):2708\u20132718. https:\/\/doi.org\/10.1016\/j.jcin.2023.08.013","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"2624_CR50","doi-asserted-by":"publisher","first-page":"e590","DOI":"10.4244\/eij-d-18-00344","volume":"14","author":"U Landmesser","year":"2018","unstructured":"Landmesser U et al (2018) Left atrial appendage occlusion with the AMPLATZER Amulet device: 1-year follow-up from the prospective global Amulet observational registry (in eng). EuroIntervention 14(5):e590\u2013e597. https:\/\/doi.org\/10.4244\/eij-d-18-00344","journal-title":"EuroIntervention"},{"issue":"11","key":"2624_CR51","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.jcin.2019.04.004","volume":"12","author":"L S\u00f8ndergaard","year":"2019","unstructured":"S\u00f8ndergaard L et al (2019) Propensity-matched comparison of oral anticoagulation versus antiplatelet therapy after left atrial appendage closure with watchman (in eng). JACC Cardiovasc Interv 12(11):1055\u20131063. https:\/\/doi.org\/10.1016\/j.jcin.2019.04.004","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"2624_CR52","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jacep.2019.11.009","volume":"6","author":"M Osman","year":"2020","unstructured":"Osman M et al (2020) Short-term antiplatelet versus anticoagulant therapy after left atrial appendage occlusion: a systematic review and meta-analysis (in eng). JACC Clin Electrophysiol 6(5):494\u2013506. https:\/\/doi.org\/10.1016\/j.jacep.2019.11.009","journal-title":"JACC Clin Electrophysiol"},{"issue":"17","key":"2624_CR53","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.jacc.2016.08.016","volume":"68","author":"T Rodriguez-Gabella","year":"2016","unstructured":"Rodriguez-Gabella T et al (2016) Single antiplatelet therapy following left atrial appendage closure in patients with contraindication to anticoagulation (in eng). J Am Coll Cardiol 68(17):1920\u20131921. https:\/\/doi.org\/10.1016\/j.jacc.2016.08.016","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2624_CR54","first-page":"385","volume":"32","author":"A Darmon","year":"2020","unstructured":"Darmon A et al (2020) Left atrial appendage closure in patients with atrial fibrillation at very high bleeding risk without postimplantation antithrombotic therapy (in eng). J Invasive Cardiol 32(10):385\u2013391","journal-title":"J Invasive Cardiol"},{"issue":"12","key":"2624_CR55","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.amjcard.2019.08.050","volume":"124","author":"JP Pouru","year":"2019","unstructured":"Pouru JP, Jaakkola S, Lund J, Biancari F, Saraste A, Airaksinen KEJ (2019) Effectiveness of only aspirin or clopidogrel following percutaneous left atrial appendage closure (in eng). Am J Cardiol 124(12):1894\u20131899. https:\/\/doi.org\/10.1016\/j.amjcard.2019.08.050","journal-title":"Am J Cardiol"},{"issue":"4","key":"2624_CR56","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.acvd.2016.09.006","volume":"110","author":"Z Jalal","year":"2017","unstructured":"Jalal Z et al (2017) Percutaneous left atrial appendage closure followed by single antiplatelet therapy: short- and mid-term outcomes (in eng). Arch Cardiovasc Dis 110(4):242\u2013249. https:\/\/doi.org\/10.1016\/j.acvd.2016.09.006","journal-title":"Arch Cardiovasc Dis"},{"issue":"1","key":"2624_CR57","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/ccd.25891","volume":"86","author":"A Aminian","year":"2015","unstructured":"Aminian A, Lalmand J, Tzikas A, Budts W, Benit E, Kefer J (2015) \"Embolization of left atrial appendage closure devices: a systematic review of cases reported with the watchman device and the amplatzer cardiac plug (in eng). Catheter Cardiovasc Interv 86(1):128\u2013135. https:\/\/doi.org\/10.1002\/ccd.25891","journal-title":"Catheter Cardiovasc Interv"},{"issue":"13","key":"2624_CR58","doi-asserted-by":"publisher","first-page":"e1038","DOI":"10.4244\/eij-d-22-00627","volume":"18","author":"DR Holmes Jr","year":"2023","unstructured":"Holmes DR Jr, Korsholm K, Rod\u00e9s-Cabau J, Saw J, Berti S, Alkhouli MA (2023) Left atrial appendage occlusion (in eng). EuroIntervention 18(13):e1038\u2013e1065. https:\/\/doi.org\/10.4244\/eij-d-22-00627","journal-title":"EuroIntervention"},{"issue":"9","key":"2624_CR59","doi-asserted-by":"publisher","DOI":"10.1161\/circinterventions.119.008112","volume":"12","author":"K Korsholm","year":"2019","unstructured":"Korsholm K, Jensen JM, N\u00f8rgaard BL, Nielsen-Kudsk JE (2019) Detection of device-related thrombosis following left atrial appendage occlusion: a comparison between cardiac computed tomography and transesophageal echocardiography (in eng). Circ Cardiovasc Interv 12(9):e008112. https:\/\/doi.org\/10.1161\/circinterventions.119.008112","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"2624_CR60","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/ehjci\/jeac222","volume":"24","author":"AD Kramer","year":"2023","unstructured":"Kramer AD et al (2023) Cardiac computed tomography following Watchman FLX implantation: device-related thrombus or device healing? (in eng). Eur Heart J Cardiovasc Imaging 24(2):250\u2013259. https:\/\/doi.org\/10.1093\/ehjci\/jeac222","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"12","key":"2624_CR61","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.jacep.2018.09.007","volume":"4","author":"M Alkhouli","year":"2018","unstructured":"Alkhouli M, Busu T, Shah K, Osman M, Alqahtani F, Raybuck B (2018) Incidence and clinical impact of device-related thrombus following percutaneous left atrial appendage occlusion: a meta-analysis (in eng). JACC Clin Electrophysiol 4(12):1629\u20131637. https:\/\/doi.org\/10.1016\/j.jacep.2018.09.007","journal-title":"JACC Clin Electrophysiol"},{"issue":"4","key":"2624_CR62","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jacc.2021.04.098","volume":"78","author":"T Simard","year":"2021","unstructured":"Simard T et al (2021) Predictors of device-related thrombus following percutaneous left atrial appendage occlusion (in eng). J Am Coll Cardiol 78(4):297\u2013313. https:\/\/doi.org\/10.1016\/j.jacc.2021.04.098","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2624_CR63","doi-asserted-by":"publisher","first-page":"E1019","DOI":"10.1002\/ccd.29458","volume":"97","author":"A Sedaghat","year":"2021","unstructured":"Sedaghat A et al (2021) Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device-Insights from the EWOLUTION real world registry (in eng). Catheter Cardiovasc Interv 97(7):E1019-e1024. https:\/\/doi.org\/10.1002\/ccd.29458","journal-title":"Catheter Cardiovasc Interv"},{"issue":"10","key":"2624_CR64","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1093\/eurheartj\/ehaa803","volume":"42","author":"HN Rashid","year":"2021","unstructured":"Rashid HN, Layland J (2021) Association between device-related thrombus and the neo-appendage with left-atrial appendage occlusion devices (in eng). Eur Heart J 42(10):1047\u20131048. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa803","journal-title":"Eur Heart J"},{"issue":"6","key":"2624_CR65","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jacep.2022.01.024","volume":"8","author":"CR Ellis","year":"2022","unstructured":"Ellis CR, Alkhouli M, Anderson JA, Swarup V (2022) Comparative endothelialization of amulet LAA occluder and watchman 2.5 LAA device: observations from explanted hearts (in eng). JACC Clin Electrophysiol 8(6):828\u2013829. https:\/\/doi.org\/10.1016\/j.jacep.2022.01.024","journal-title":"JACC Clin Electrophysiol"},{"issue":"17","key":"2624_CR66","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1161\/circulationaha.119.040860","volume":"140","author":"L Asmarats","year":"2019","unstructured":"Asmarats L et al (2019) Recurrence of device-related thrombus after percutaneous left atrial appendage closure (in eng). Circulation 140(17):1441\u20131443. https:\/\/doi.org\/10.1161\/circulationaha.119.040860","journal-title":"Circulation"},{"issue":"6","key":"2624_CR67","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jcin.2022.12.006","volume":"16","author":"M Alkhouli","year":"2023","unstructured":"Alkhouli M et al (2023) Peridevice leak after left atrial appendage occlusion: incidence, mechanisms, clinical impact, and management (in eng). JACC Cardiovasc Interv 16(6):627\u2013642. https:\/\/doi.org\/10.1016\/j.jcin.2022.12.006","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"2624_CR68","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jcin.2020.10.034","volume":"14","author":"K Korsholm","year":"2021","unstructured":"Korsholm K et al (2021) Peridevice leak following amplatzer left atrial appendage occlusion: cardiac computed tomography classification and clinical outcomes (in eng). JACC Cardiovasc Interv 14(1):83\u201393. https:\/\/doi.org\/10.1016\/j.jcin.2020.10.034","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"2624_CR69","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10840-022-01336-4","volume":"66","author":"K Korsholm","year":"2023","unstructured":"Korsholm K et al (2023) Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device (in eng). J Interv Card Electrophysiol 66(2):391\u2013401. https:\/\/doi.org\/10.1007\/s10840-022-01336-4","journal-title":"J Interv Card Electrophysiol"},{"issue":"10","key":"2624_CR70","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jacc.2011.11.028","volume":"59","author":"JF Viles-Gonzalez","year":"2012","unstructured":"Viles-Gonzalez JF et al (2012) The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy (in eng). J Am Coll Cardiol 59(10):923\u2013929. https:\/\/doi.org\/10.1016\/j.jacc.2011.11.028","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2624_CR71","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jacep.2021.06.018","volume":"8","author":"MR Afzal","year":"2022","unstructured":"Afzal MR et al (2022) Temporal changes and clinical implications of delayed peridevice leak following left atrial appendage closure (in eng). JACC Clin Electrophysiol 8(1):15\u201325. https:\/\/doi.org\/10.1016\/j.jacep.2021.06.018","journal-title":"JACC Clin Electrophysiol"},{"issue":"6","key":"2624_CR72","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.jacep.2022.03.001","volume":"8","author":"M Alkhouli","year":"2022","unstructured":"Alkhouli M et al (2022) Clinical impact of residual leaks following left atrial appendage occlusion: insights from the nCDR LAAO Registry (in eng). JACC Clin Electrophysiol 8(6):766\u2013778. https:\/\/doi.org\/10.1016\/j.jacep.2022.03.001","journal-title":"JACC Clin Electrophysiol"},{"issue":"5","key":"2624_CR73","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jacc.2022.04.062","volume":"80","author":"SR Dukkipati","year":"2022","unstructured":"Dukkipati SR et al (2022) Impact of peridevice leak on 5-year outcomes after left atrial appendage closure (in eng). J Am Coll Cardiol 80(5):469\u2013483. https:\/\/doi.org\/10.1016\/j.jacc.2022.04.062","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2624_CR74","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/eurheartj\/ehad828","volume":"45","author":"A Samaras","year":"2024","unstructured":"Samaras A et al (2024) Residual leaks following percutaneous left atrial appendage occlusion and outcomes: a meta-analysis (in eng). Eur Heart J 45(3):214\u2013229. https:\/\/doi.org\/10.1093\/eurheartj\/ehad828","journal-title":"Eur Heart J"},{"issue":"12","key":"2624_CR75","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.jacep.2021.06.002","volume":"7","author":"DG Della Rocca","year":"2021","unstructured":"Della Rocca DG et al (2021) Radiofrequency energy applications targeting significant residual leaks after watchman implantation: a prospective, multicenter experience (in eng). JACC Clin Electrophysiol 7(12):1573\u20131584. https:\/\/doi.org\/10.1016\/j.jacep.2021.06.002","journal-title":"JACC Clin Electrophysiol"},{"issue":"6","key":"2624_CR76","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1002\/ccd.30139","volume":"99","author":"AM Killu","year":"2022","unstructured":"Killu AM et al (2022) Leak closure following left atrial appendage exclusion procedures: a multicenter registry (in eng). Catheter Cardiovasc Interv 99(6):1867\u20131876. https:\/\/doi.org\/10.1002\/ccd.30139","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"2624_CR77","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.hrthm.2021.01.030","volume":"18","author":"DR Musikantow","year":"2021","unstructured":"Musikantow DR et al (2021) Transcatheter embolic coils to treat peridevice leaks after left atrial appendage closure (in eng). Heart Rhythm 18(5):717\u2013722. https:\/\/doi.org\/10.1016\/j.hrthm.2021.01.030","journal-title":"Heart Rhythm"},{"issue":"12","key":"2624_CR78","doi-asserted-by":"publisher","first-page":"e1033","DOI":"10.4244\/eij-d-21-00286","volume":"17","author":"K Piayda","year":"2021","unstructured":"Piayda K et al (2021) \"Safety and feasibility of peri-device leakage closure after LAAO: an international, multicentre collaborative study (in eng). EuroIntervention 17(12):e1033\u2013e1040. https:\/\/doi.org\/10.4244\/eij-d-21-00286","journal-title":"EuroIntervention"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02624-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-025-02624-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02624-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T08:39:48Z","timestamp":1778488788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-025-02624-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2624"],"URL":"https:\/\/doi.org\/10.1007\/s00392-025-02624-5","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"8 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}